This inventor holds 3 USPTO granted patents. Top assignees: Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag, Teva Gyógyszergyár Zárkörüen Müködö Részvénytársaság. Active years: 2006-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2006-2008
Title: Erzsebet Meszaros Sos: Innovator in Pharmaceutical Chemistry
Introduction
Erzsebet Meszaros Sos is a notable inventor based in Debrecen, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. With a total of two patents to her name, her work has implications for the development of essential medications.
Latest Patents
One of her latest patents is titled "Preparation of Aztreonam." This invention relates to a process for the synthesis of Aztreonam, specifically involving the hydrolysis of a complex compound to form the desired antibiotic. Another significant patent is for a "Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one." This process improves upon existing methods for synthesizing ondansetron, showcasing a rapid rate, selectivity, and ease of product isolation.
Career Highlights
Throughout her career, Erzsebet has worked with prominent companies in the pharmaceutical industry, including Teva Pharmaceutical Industries Ltd. and Teva Gyógyszergyár Zártkörűen Működő Részvénytársaság. Her experience in these organizations has allowed her to refine her skills and contribute to innovative drug development.
Collaborations
Erzsebet has collaborated with several professionals in her field, including Csaba Szabo and Szabolcs Salyi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Erzsebet Meszaros Sos is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug synthesis. Her contributions continue to impact the field positively, demonstrating her commitment to innovation and excellence.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile